Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario / Factors associated with success of a smoking cessation program
Rev. méd. Chile
;
144(8): 965-971, ago. 2016. ilus, tab
Article
Dans Espagnol
| LILACS
| ID: biblio-830600
ABSTRACT
Background:
Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication available.Aim:
To study risk factors for the failure of pharmacological smoking cessation therapy with varenicline. Patients andMethods:
Retrospective analysis of 281 patients aged 45 ± 11 years (65% males) with a mean consumption of 31 ± 22 packs/year. They completed a smoking cessation program comprising psychological support and use of varenicline in a private clinic. Patients were followed with telephonic interviews during one year. A complete abstinence during one year was considered as a success of the program.Results:
The success rate of the program was 53.4%. The factors associated with failure were a high tobacco dependence rate determined with the Fageström test (Odds ratio (OR) 2.47, 95% confidence intervals (CI) 1.16-5.26, p = 0.02). An instruction level of more than 12 years was associated with a lower failure rate (OR 0.38 95% CI 0.18-0.82).Conclusions:
A high tobacco dependence rate and a lower education were associated with a higher failure rate of this smoking cessation program.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Évaluation de programme
/
Fumer
/
Arrêter de fumer
/
Agonistes nicotiniques
/
Varénicline
Type d'étude:
Études d'évaluation
/
Facteurs de risque
Limites du sujet:
Adulte
/
Adulte très âgé
/
Femelle
/
Humains
/
Mâle
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
2016
Type:
Article
Pays d'affiliation:
Chili
Institution/Pays d'affiliation:
Clínica Santa María/CL
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS